A new Ti-catalyzed cross-cyclomagnesiation of aliphatic and
oxygenated 1,2-dienes with Et
Thymidylate synthase (ThS) is
a target for antimetabolite antitumor drugs. Such drugs have been
Khusnutdinova, E.K.,
Dzhemileva, L.U.,
Lobov, S.L.,
Kuznetzov, D.U.,
Nazirova, A.G.,
Nurgalina, E.M.,
Barashkov, N.A.,
Fedorova, S.A. (2017) , 12SrRNA, tRNASer (UCN),
SLC26
A4 and SLC26
A5 in patients with non-syndromic sensorineural
hearing loss
Mykola, A.,
Malievskiy, O,
Nataliya, Z,
Bolshova, EV,
Senatorova, G,
Oroszlan, G,
Skorodok, J,
Peterkova, V,
Nataliya, C,
Sorokman, T,
Yang, S,
Lee, JE,
Muzsnai, A,
Hwang, JS,
Kim, T,
Choi, YJ,
Woo, J,
Jang, WI,
Sung, YC,
Keyoung, M (2017) A HYBRID FC-FUSED HUMAN GROWTH HORMONE, GX-H9, SHOWS
A POTENTIAL FOR WEEKLY AND TWICE
THE OFF-LABEL USE OF DRUGS FOR PARENTERAL NUTRITION AS
A SOLVENT OF SUBSTANCES SLIGHTLY SOLUBLE
. With
increasing severity of the clinical course,
a significant decrease in the level of iron was observed mainly
Afolabi, A.,
Hu, SN.,
Wang, C.,
Zhu, YC.,
Mustafina, I.,
Lin, L.,
Zheng, GH.,
Zhe, CY.,
Jia, HB.,
Hou, JB.,
Yu, B. (2017) burden in high-income countries. ACS refers to
a constellation of clinical symptoms that are compatible